Skip to content. | Skip to navigation



About us

A premier contract development and manufacturing organization (CDMO), Vetter is a global leader in the fill & finish contract manufacturing of aseptically prefilled syringe systems, cartridges, and vials. We are a family-owned, independent company with facilities both in Germany and the US, as well as offices in Singapore and Japan. Our focus is on providing state-of-the-art manufacturing, from early clinical development and scale-up to commercial filling and packaging of parenteral drugs. We support you every step of the way, guiding your product through development, regulatory approval, launch, and life cycle management. Vetter offers you a foundation of experience spanning more than 35 years including dozens of product approvals for novel pharmaceutical and biotech compounds.

Vetter Answers


The path to market in a dual-chamber system

As the global demand for injectable systems grows, so does the demand for new, innovative delivery options such as dual-chamber technology. With a dual-chamber system, some alterations to a typical development approach are needed in order to facilitate a compound is suitable for this delivery system as well as determine the optimal cycle. What are typical steps along the development path?

Vetter Newsroom

Vetter is a winner of the AbbVie TRIUMPH AWARD

Customer award from one of the top-20 biopharmaceutical companies was granted for meeting ‘predetermined high-level demands of service’. 

Board of directors of the German American Chamber of Commerce® 

Susanne Resatz, President of Vetter Development Services USA, Inc. is elected to the board of directors of the German American Chamber of Commerce® of the Midwest, Inc.